Mail

UK markets closed

FTSE 100
8,420.26
-18.39(-0.22%)
FTSE 250
20,749.90
-72.94(-0.35%)
AIM
794.02
+1.52(+0.19%)
GBP/EUR
1.1678
+0.0023(+0.20%)
GBP/USD
1.2706
+0.0035(+0.28%)
Bitcoin GBP
52,535.05
+1,194.21(+2.33%)

9 houses with great-looking gardens

Check out these homes if inspiring outside space tops your property wish list

Medigen Biotechnology Corp. (3176.TWO)

Taipei Exchange - Taipei Exchange Delayed price. Currency in TWD

Add to watchlist

42.00

+2.30

(+5.79%)

At close: 01:30PM CST

Currency in TWD

Valuation measures⁴

Market cap (intra-day)	5.53B
Enterprise value	4.11B
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	4.45
Price/book (mrq)	3.56
Enterprise value/revenue	3.30
Enterprise value/EBITDA	8.98

Trading information

Stock price history

Beta (5Y monthly)	0.59
52-week change ³	20.49%
S&P500 52-week change ³	26.36%
52-week high ³	62.40
52-week low ³	30.30
50-day moving average ³	39.13
200-day moving average ³	40.56

Share statistics

Avg vol (3-month) ³	283.05k
Avg vol (10-day) ³	234.9k
Shares outstanding ⁵	139.35M
Implied shares outstanding ⁶	139.35M
Float ⁸	130.21M
% held by insiders ¹	25.22%
% held by institutions ¹	2.79%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-48.48%
Operating margin (ttm)	-149.39%

Management effectiveness

Return on assets (ttm)	-8.33%
Return on equity (ttm)	-25.64%

Income statement

Revenue (ttm)	1.16B
Revenue per share (ttm)	8.31
Quarterly revenue growth (yoy)	82.10%
Gross profit (ttm)	N/A
EBITDA	-1.08B
Net income avi to common (ttm)	-561.3M
Diluted EPS (ttm)	-3.89
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	4.59B
Total cash per share (mrq)	32.92
Total debt (mrq)	2.86B
Total debt/equity (mrq)	57.33%
Current ratio (mrq)	2.05
Book value per share (mrq)	11.42

Cash flow statement

Operating cash flow (ttm)	-503.52M
Levered free cash flow (ttm)	-190.22M